UY29227A1 - SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG - Google Patents

SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG

Info

Publication number
UY29227A1
UY29227A1 UY29227A UY29227A UY29227A1 UY 29227 A1 UY29227 A1 UY 29227A1 UY 29227 A UY29227 A UY 29227A UY 29227 A UY29227 A UY 29227A UY 29227 A1 UY29227 A1 UY 29227A1
Authority
UY
Uruguay
Prior art keywords
drospirenone
dissolution
pharmaceutical composition
speed
combination
Prior art date
Application number
UY29227A
Other languages
Spanish (es)
Inventor
Gustavo Andrade
Carlos Zanetti
Original Assignee
Gador Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador Sa filed Critical Gador Sa
Publication of UY29227A1 publication Critical patent/UY29227A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una composición farmacéutica asegurando una velocidad de disolución y homogenización de la droga no micronizada logrando una estabilidad físico-química inesperada.También con la composición farmacéutica obtenida por ese proceso y el uso de la composición farmacéutica para preparar un medicamento. La composición farmacéutica comprende, una combinación de dos principios activos, a saber drospirenona y etinilestradiol, un agente surfactante y excipientes farmacéuticamente aceptables con la condición de que la drospirenona presente la siguiente distribución: aproximadamente el 95% de ellos presenten un tamano de partícula inferior a 100 um (micrómetros), aproximadamente el 26 % presente un tamano de partícula inferior a 20 um (micrómetros) y aproximadamente el 15% presente un tamano de partícula inferior a 10.00 um (micrómetros), o con la condición de que dichos principios activos presenten una área superficial menos a 10000cm2/g o con la condición que la drospirenona no se encuentra en forma micronizada. Esta composición es usada para inhibir la ovulación y los cambios en la secreción cervical.The present invention relates to a pharmaceutical composition ensuring a speed of dissolution and homogenization of the non-micronized drug achieving an unexpected physical-chemical stability. Also with the pharmaceutical composition obtained by that process and the use of the pharmaceutical composition to prepare a medicament. The pharmaceutical composition comprises, a combination of two active ingredients, namely drospirenone and ethinyl estradiol, a pharmaceutically acceptable surfactant and excipients with the proviso that drospirenone has the following distribution: approximately 95% of them have a particle size of less than 100 um (micrometers), approximately 26% have a particle size of less than 20 um (micrometers) and approximately 15% have a particle size of less than 10.00 um (micrometers), or with the condition that said active substances have a surface area less than 10000cm2 / g with the condition that drospirenone is not in a micronized form. This composition is used to inhibit ovulation and changes in cervical secretion.

UY29227A 2004-12-28 2005-11-24 SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG UY29227A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP040104928 AR047782A1 (en) 2004-12-28 2004-12-28 SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE

Publications (1)

Publication Number Publication Date
UY29227A1 true UY29227A1 (en) 2005-12-30

Family

ID=36607162

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29227A UY29227A1 (en) 2004-12-28 2005-11-24 SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG

Country Status (4)

Country Link
AR (1) AR047782A1 (en)
CO (1) CO5770093A1 (en)
PE (1) PE20061112A1 (en)
UY (1) UY29227A1 (en)

Also Published As

Publication number Publication date
PE20061112A1 (en) 2006-11-27
AR047782A1 (en) 2006-02-22
CO5770093A1 (en) 2007-06-29

Similar Documents

Publication Publication Date Title
AU2010339867B2 (en) Nestorone/estradiol transdermal gel
MEP38008A (en) Drospirenone for hormone replacement therapy
MA26843A1 (en) NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
BR9911073A (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute asthma condition
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AR056609A1 (en) STABILIZED COMPOSITIONS OF LANTAN CARBONATE
TW200514560A (en) Pharmaceutical formulation for contraception and hormone-replacement therapy
AR034900A1 (en) USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
KR102433001B1 (en) Usage and Dosage of Endometriosis Treatment
BR0210595A (en) Dosage regimen and pharmaceutical composition for emergency contraception
BR0114665A (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
BR0309057A (en) Low dosage liquid formulations in entecavir and use
AR036970A1 (en) ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION
CO5241355A1 (en) PACKAGED FORM OF ACTIVE NUCLEOSIDIC PHARMACEUTICAL COMPOSITIONS FOR VACCINES AGAINST HEPATITIS
UY29227A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG
AR063111A1 (en) A PHARMACEUTICAL FORMULATION OF TAXANO
BR0006556A (en) Pharmaceutical composition for topical use of corticosteroids for the treatment of phimosis
AR044450A1 (en) COMPOSITION THAT INCLUDES ANTAGONISTS OF PROGESTERONE RECEPTORS AND PURE ANTIESTROGENS FOR THE PROPHYLAXIS AND TREATMENT OF HORMONE DEPENDENT DISEASES
DOP2005000278A (en) SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENON, ETHYLINESTRADIOL AND A SUITABLE SURFACTANT AGENT THAT PRESENT A HOMOGENEITY OF CONTAINED SPEED AND SPEED OF DRUG FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION FOR COMPOSITION PREPARATION.
MA33808B1 (en) SUSPENDED, SUSTAINED, LOW AND ULTRA LOW SUSPENSION PHARMACEUTICAL FORMULATION FOR USE IN MENOPAUSIC SYNDROME HORMONE THERAPY
BR112022023635A2 (en) DRUG RELEASE SYSTEM FOR OPHTHALMIC USE
AR043470A2 (en) A PHARMACEUTICAL COMPOSITION TO BE USED AS AN CONTRACEPTIVE
Sitruk-Ware et al. Patent: Nestorone®/estradiol transdermal gel
BR0312003A (en) Metastable pharmaceutical compositions for transdermal delivery and their uses
AR026747A1 (en) EPERENONA CRYSTAL FORM

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160726